Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial
BMJ · 20.11.2019 · l6131
DOI: 10.1136/bmj.l6131 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BMJ, online erschienen am 20.11.2019. Verfasst von Ulla-Britt Wennerholm und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Sahlgrenska University Hospital…. Hauptthemen laut MEDLINE: Gestational Age, Infant, Newborn, Diseases, Labor, Induced. Die Arbeit wurde bisher 151-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To evaluate if induction of labour at 41 weeks improves perinatal and maternal outcomes in women with a low risk pregnancy compared with expectant management and induction of labour at 42 weeks.
Design
Multicentre, open label, randomised controlled superiority trial.
Setting
14 hospitals in Sweden, 2016-18.
Participants
2760 women with a low risk uncomplicated singleton pregnancy randomised (1:1) by the Swedish Pregnancy Register. 1381 women were assigned to the induction group and 1379 were assigned to the expectant management group.
Interventions
Induction of labour at 41 weeks and expectant management and induction of labour at 42 weeks. Main outcome measures The primary outcome was a composite perinatal outcome including one or more of stillbirth, neonatal mortality, Apgar score less than 7 at five minutes, pH less than 7.00 or metabolic acidosis (pH 12 mmol/L) in the umbilical artery, hypoxic ischaemic encephalopathy, intracranial haemorrhage, convulsions, meconium aspiration syndrome, mechanical ventilation within 72 hours, or obstetric brachial plexus injury. Primary analysis was by intention to treat.
Results
The study was stopped early owing to a significantly higher rate of perinatal mortality in the expectant management group. The composite primary perinatal outcome did not differ between the groups: 2.4% (33/1381) in the induction group and 2.2% (31/1379) in the expectant management group (relative risk 1.06, 95% confidence interval 0.65 to 1.73; P=0.90). No perinatal deaths occurred in the induction group but six (five stillbirths and one early neonatal death) occurred in the expectant management group (P=0.03). The proportion of caesarean delivery, instrumental vaginal delivery, or any major maternal morbidity did not differ between the groups.
Conclusions
This study comparing induction of labour at 41 weeks with expectant management and induction at 42 weeks does not show any significant difference in the primary composite adverse perinatal outcome. However, a reduction of the secondary outcome perinatal mortality is observed without increasing adverse maternal outcomes. Although these results should be interpreted cautiously, induction of labour ought to be offered to women no later than at 41 weeks and could be one (of few) interventions that reduces the rate of stillbirths.
Trial registration
Current Controlled Trials ISRCTN26113652 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Sahlgrenska University Hospital, 416 85 Gothenburg, Sweden ulla-britt.wennerholm@vgregion.se.
- Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Institute of Health and Care Sciences, Sahlgrenska Academy, Gothenburg University, Sweden.
- Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Sahlgrenska University Hospital, 416 85 Gothenburg, Sweden.
- Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
ORCID-Profile: Ulla-Britt Wennerholm, Sissel Saltvedt, Anna Wessberg, Mårten Alkmark, Christina Bergh, Sophia Brismar Wendel, Helena Fadl, Maria Jonsson, Lars Ladfors, Verena Sengpiel, Jan Wesström, Göran Wennergren, Anna-Karin Wikström, Helen Elden, Olof Stephansson, Henrik Hagberg
Zitieren
APA
Wennerholm, U. B., Saltvedt, S., Wessberg, A., Alkmark, M., Bergh, C., Wendel, S. B., Fadl, H., Jonsson, M., Ladfors, L., Sengpiel, V., Wesström, J., Wennergren, G., Wikström, A. K., Elden, H., Stephansson, O., & Hagberg, H. (2019). Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial. BMJ, l6131. https://doi.org/10.1136/bmj.l6131
Vancouver
Wennerholm UB, Saltvedt S, Wessberg A, Alkmark M, Bergh C, Wendel SB, et al. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial. BMJ. 2019:l6131. doi:10.1136/bmj.l6131
BibTeX
@article{Wennerholm2019,
author = {Wennerholm, Ulla-Britt and Saltvedt, Sissel and Wessberg, Anna and Alkmark, Mårten and Bergh, Christina and Wendel, Sophia Brismar and Fadl, Helena and Jonsson, Maria and Ladfors, Lars and Sengpiel, Verena and Wesström, Jan and Wennergren, Göran and Wikström, Anna-Karin and Elden, Helen and Stephansson, Olof and Hagberg, Henrik},
title = {Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial},
journal = {BMJ},
year = {2019},
pages = {l6131},
doi = {10.1136/bmj.l6131}
}
EUVIMED